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Numerous publications and commercial systems are available that deal with auto-
matic detection of pulmonary nodules in thoracic computed tomography scans, but a
comparative study where many systems are applied to the same data set has not yet
been performed. This paper introduces ANODE09 (http://anode09.isi.uu.nl), a
database of 55 scans from a lung cancer screening program and a web-based frame-
work for objective evaluation of nodule detection algorithms. Any team can upload
results to facilitate benchmarking. The performance of six algorithms for which results
are available are compared; five from academic groups and one commercially available
system. A method to combine the output of multiple systems is proposed. Results
show a substantial performance difference between algorithms, and demonstrate that
combining the output of algorithms leads to marked performance improvements.
Keywords: Computer-aided detection, computed tomography, lung nodules, lung cancer
1 Introduction
Computer-aided detection (CAD) has become one of the most active research areas within
medical image analysis. The detection of pulmonary nodules from volumetric computed
tomography (CT) scans is one of the most studied CAD applications [57]. There are several
reasons for the interest in this task. First, lung cancer is the most deadly cancer and early
detection may be the most promising strategy to reduce lung cancer mortality. With CT,
small lung nodules can be identified. If these nodules are malignant, they usually represent
early stage lung cancer and with surgical intervention there is a high chance of long-term
survival of the patient [43]. Second, the advent of multi-detector row CT scanners with fast
gantry rotation times has made it possible to scan the entire chest in a few seconds, well
within a single breath-hold. This generates high quality scans with isotropic voxels around
0.35 mm3, that can be obtained with a low dose and high patient throughput. As a result,
there are currently many ongoing trials that investigate the efficacy and effectiveness of lung
cancer screening with low dose CT among high risk individuals [25, 31, 33, 59]. In addition
to screening, chest CT exams are being used more often for a wide range of diagnostic
tasks. It is always important to report findings of nodules in these scans, and this can be a
cumbersome, time-consuming task because the scans contain 300 to 500 slices. It appears
best to use dedicated visualization settings (sliding maximum intensity projections of around
10 mm) for optimal detection performance [29], but such settings may not be optimal for the
detection of other abnormalities. CAD of nodules may therefore become a practical necessity
for time-efficient interpretation of chest CT scans.
Although at first glance the detection of nodules may seem a fairly straightforward task,
it turns out that nodules come in many forms. There are nodules that are easy to detect,
for example a round, well-marginated, solid nodule of 4 to 10 mm in diameter, located in
the periphery of the lung. But much smaller nodules are also visible on CT, and there are
nodules with complex vascular attachments located in regions with large vessels, and part-
solid and non-solid nodules with densities only slightly above those of the surrounding lung
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parenchyma. If a scan contains abnormalities, the lungs may contain many lesions that are
somewhat nodular in appearance, but unrelated to lung cancer. It is therefore difficult, if
not meaningless, to compare the performance of two nodule CAD systems that have been
tested on different databases. Another reason why it is hard to compare results obtained on
different databases is that many studies, especially older ones, have used scans with thick
sections, in the range of 2.5 to 10 mm. For the detection of nodules, such thick sections are
not recommended.
A large number of systems for nodule detection have been proposed in the literature
[3–5, 10, 11, 13, 17, 19, 20, 22, 23, 35, 37, 39, 42, 44–47, 49, 51, 52, 54, 58, 62–64, 66–
68]. In addition, several commercial systems for nodule detection are available and many
workstations that radiologists routinely use to interpret CT scans provide on-board nodule
detection capabilities. The reported performance of systems varies tremendously. In a recent
literature survey [40], a comparison of nine systems yielded sensitivities from 70% to 90%
with a range of 0.5 to 15 false positive detections per scan. Even when the same CAD system
is evaluated, results can vary substantially. A study from 2005 [38] measured performance
of the ImageChecker CT LN-1000, developed by R2 Technology (Sunnyvale, CA). This
technology has been acquired by Mevis (Pewaukee, WI) and recently released as Visia CT
Lung. The system was applied to 70 scans with 78 nodules. CAD detected 47 (60%) of these
and produced 1.56 false-positive nodules per scan. In another study [15], the ImageChecker
CT (no version number was given) obtained 73% sensitivity and 6 false positives (FPs) per
scan. Finally, in a recent study [24] the results for ImageChecker CT V2.0, in a study partly
funded by R2 Technology, achieved a sensitivity of 87.7% for lung cancer nodules with a
diameter of 4 mm and larger with either solid or semi-solid morphology, at a false positive
rate of 0.9 per scan.
A major step forward to more objective measurement of CAD performance is the cre-
ation of a publicly available database by the Lung Image Database Consortium (LIDC) [6].
Annotated chest CT scans are available on-line at https://imaging.nci.nih.gov/ncia/.
So far, this collection contains 400 scans. One of the LIDC groups also made data avail-
able at http://www.via.cornell.edu/databases/lungdb.html. Because the data and
annotations are freely available, companies and research groups may report their results on
different subsets of the databases and will almost certainly perform evaluation in different
ways, making the results again difficult to compare.
The purpose of this paper is to present a new database of state-of-the-art CT scans from a
lung cancer screening trial, and a framework for the evaluation of CAD algorithms applied to
this data set. To alleviate the problem that observers tend to show substantial disagreement
on what constitutes a nodule [8], we introduce the concept of relevant and irrelevant findings.
Irrelevant findings are nodules that are unlikely to be cancer, such as calcified nodules or
very small nodules. These irrelevant findings have been marked in the database and if a
CAD system detects such a lesion, the output of the system is ignored (i.e., not counted as
either a true positive or a false positive). Evaluation is performed using free-response receiver
operating characteristic (FROC) analysis and the results are computed automatically after
a list of the coordinates of findings, along with a degree of suspicion generated by the CAD
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system is submitted to the ANODE09 web site (http:\\anode09.isi.uu.nl). This ensures
that every system is evaluated in exactly the same way, using the same software, and that
the results are directly comparable. The only factors affecting differences in results then
would be the CAD system, not the data or the details of the evaluation procedure. This
paper describes the database and the evaluation procedure in detail in Sections 2 and 3. In
Section 4 six systems whose findings have been submitted are described and their results
are given in Section 5. They include recent and older CAD systems developed by academic
groups and one commercial system.
The other major contribution of this paper is a generic method to combine the output
of multiple CAD systems, outlined in Section 4.7. This is perhaps an even more compelling
reason to have organized the ANODE09 study. There is in fact no reason to assume that a
single CAD scheme would be optimal for nodule detection. It is more likely that different
methods have complementary strengths, and the availability of multiple system’s outputs on
a single database allows us to test this in practice. It will be shown that combining CAD
systems can substantially improve the overall performance. The implications and limitations
of this study are discussed in Section 6 and we draw conclusions in Section 7.
2 Data
The ANODE09 data set consists of 55 anonymized CT scans. Five scans are examples and
are made available with radiologist annotations. These scans are not used in the evaluation
of algorithms and can be used for training CAD algorithms or optimizing their internal
settings, if desired. The remaining fifty scans are for testing. The reference annotations for
those fifty scans are not publicly available.
All data has been provided by the University Medical Center Utrecht and originates
from the NELSON study, the largest CT lung cancer screening trial in Europe. Current and
former heavy smokers, mainly men, aged 50 to 75 years are included in this study. Scans were
acquired on a 16 or 64-slice CT scanner (Philips Medical Systems, Cleveland, OH) using a
spiral mode with 16×0.75 mm or 64×0.75 mm collimation. The entire chest was scanned in
4 to 10 seconds using a caudo-cranial scan direction to minimize breathing artifacts. Scans
were performed in full inspiration, without spirometric control. Exposure settings were low-
dose: 30 mAs and 120 kVp (volume CT dose index, CTDIvol = 2.2 mGy) for patients
weighing less than 80 kg, and 30 mAs at 140 kVp for those weighing over 80 kg (CTDIvol
= 3.5 mGy). Axial images with a 512×512 matrix were reconstructed at 1.0 mm thickness
and 0.7 mm increment, using a moderately soft reconstruction kernel (Philips B) and the
smallest field of view that included the outer rib margins at the widest dimension of the
thorax. As a result of this scanning procedure, where the field of view is adjusted to patient
size, the resolution in the x and y-direction varied from 0.59 to 0.83 mm with an average of
0.71. The data is therefore nearly isotropic. More information about the acquisition process
and the screening study from which the data originates is available elsewhere [60, 65].
The large majority of the ANODE09 scans were randomly selected from the entire Utrecht
database of the NELSON screening program. A small number of scans were randomly
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picked from the 1% of scans in the entire database which contained the largest number
of annotations. Scans that contained evident interstitial lung disease, which can lead to
the presence of hundreds of usually small nodular findings, were excluded. The reason for
adding some scans with more than the average number of findings is that we aimed to have
a reasonable number of nodules in a test set that was not too large, to make web-based
distribution of the data feasible.
It should be noted that the ANODE09 data set contains relatively few larger nodules,
especially compared to other databases on which results for nodule CAD systems have been
reported in the literature. We did not, as was done for example in [22], specifically add cases
with larger nodules. The ANODE09 set can be considered representative of findings among
asymptomatic heavy smokers.
3 Annotation and evaluation
3.1 Annotation process and irrelevant findings
In the NELSON study, nodules – defined as a round opacity, at least moderately well mar-
ginated and no greater than 3 cm in maximum diameter [9] – were divided into four groups
according to the protocol outlined in [65]. Class 1 contained nodules with fat, benign calcifi-
cations or other benign characteristics. The other groups contained nodules without benign
characteristics. Class 2 nodules had a volume below 50 mm3. All volume measurements were
done in 3D on Siemens workstations using the Syngo Lungcare software package (Somaris/5
VB 10A-W). If 3D segmentation failed, a diameter was drawn on an axial section. Class
3 contained solid, part-solid or non-solid nodules with a volume between 50 and 500 mm3
or an equivalent diameter1. Larger nodules fell into class 4 and participants with such a
nodule were referred to a pulmonologist for work-up and diagnosis. Participants with a class
3 nodule were invited for a 3 month repeat scan. Scans were read by an experienced observer
and by a second experienced observer in an unblinded fashion.
From our experience in the NELSON study we have learnt that it is not easy to distin-
guishing nodules from findings that mimic a nodule. This is also supported by the literature,
e.g. [38]. Most of these findings are scars, but other examples are vessels with a local out-
pouching and pleural plaques. The LIDC study [6–8] has made explicit the variation among
radiologists in the identification of lung nodules. In the LIDC study four observers indicated
nodules in 90 chest CT scans in a two step process, first blinded, next unblinded, so that
they could see the results of the three other readers. It was found [50] that for nodules ≥ 3
mm, there were 174 nodules where at least 1 of 4 observers said it was a nodule, for 146 of
those at least 2 of 4 observers agreed, for 121 at least 3 agreed and for 90 all four agreed.
These results indicate that there is a large number of nodules for which human expert ob-
servers agree, but an approximately equally large group of findings about which there is no
1The effective or equivalent diameter of a nodule is the diameter of a sphere with the same volume as a
3D segmentation of that nodule. Throughout this paper we give the size of nodules in mm and these lengths
always mean effective diameter and are usually derived from a 3D segmentation.
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consensus among observers. If a CAD system placed a marker on such a nodule, should it
be considered a true positive or a false positive?
To partly circumvent this problem, we introduced a second category of findings in the
ANODE09 study. We call this category ‘irrelevant findings’, as opposed to ‘relevant’ or
actionable findings, i.e. the nodules that a CAD system definitively should detect. Any
CAD marks in regions around irrelevant findings are ignored in the evaluation, as explained
in Section 3.2. There are three types of irrelevant findings: findings that mimic a nodule
but that an expert observer believes not to be a nodule, nodules with benign characteristics
(class 1 in the NELSON protocol), and nodules that are too small to be relevant.
Almost all very small lung nodules are benign and are normal pulmonary lymph nodes
or small granulomas [32]. Here one needs to use a threshold for volume or effective diameter.
We decided to use the threshold of 4 mm effective diameter, because it is the one currently
recommended by the Fleischner Society [43] and many CAD systems use this threshold as
well. This is a slightly smaller size than what is used in the NELSON study. In some scans
with many nodules, some nodules were also listed as irrelevant (and thus ignored in the
evaluation) although they did meet all the requirements of relevant nodules. This was done
to prevent the results of a CAD algorithm on a few scans dominating the assessment of its
performance.
The rationale for introducing irrelevant findings is that it is unfair or debatable to call
a mark on such a finding a false positive. Accurate segmentation of nodules is an extraor-
dinarily difficult task [16] and therefore in ANODE09 a mark on a nodule slightly below 4
mm in diameter according to our segmentation will not count as an error. Similarly, a mark
on a calcified nodule may be appreciated by some radiologists and should not count as an
error. As it is difficult to distinguish scarring and other abnormalities from nodules that
may represent lung cancer, it would be unfair to count a mark on such a lesion as wrong as
an obvious false positive that is placed, for example, on a vessel bifurcation.
To implement this, two observers annotated in a blinded fashion all 55 ANODE09 scans
using the NELSON annotations as a basis and adding irrelevant findings. One observer was a
very experienced reader from the NELSON trial, the other one was a radiologist in training.
A third experienced radiologist resolved cases where the two observers disagreed. All find-
ings were segmented with an in house implementation of an algorithm comparable to [36],
where the parameters were adjusted interactively by a human operator until a satisfactory
segmentation was obtained. Findings below 4 mm were listed as irrelevant. In the 50 test
scans of the ANODE09 set we recorded 207 relevant and 433 irrelevant findings. In the five
example scans 39 relevant nodules and 31 irrelevant findings were annotated.
For each annotation the scan name, x, y, z coordinates of the point clicked by the observer
and diameter were stored. In addition, for each relevant finding it was recorded if it was in
contact with the pleura (29%), a fissure (17%), or a vessel (42%). This was done based on
visual assessment by one observer. It is especially difficult to judge if a nodule is in contact
with vasculature. Probably all nodules are in contact with very small vessels close to or below
the resolution of a CT scan, so it is hard to draw the distinction. This issue is not so critical;
the categorization was only made to allow us to define different groups of nodules and report
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performance of methods for different subsets: pleural nodules, peri-fissural nodules, vascular
nodules and isolated nodules. Note that a nodule can belong to more than one category
of the first three. A nodule is isolated if it is not in contact with the pleura, a fissure or a
vessel. This was the case for 20% of all nodules. Nodules were also divided into small and
large nodules. The cut-off point was chosen to be 5 mm. At this point, 45% of nodules were
large. Although the difference between a 4 or 5 mm nodule may seem small, note that it
corresponds to almost a doubling in volume. Few nodules were above 7 mm (10%) and very
few above 9 mm (2%). The densities of nodules varied, from calcified (irrelevant findings)
to solid, to part-solid and non-solid. Part-solid and non-solid nodules were not included as
separate categories as these were relatively rare among the relevant findings. Examples of
different types of nodules and irrelevant findings are given in Figure 1.
3.2 Evaluation: hit criterion
The results of CAD systems that have processed the test scans must be submitted on-line in
the form of a text file with a set S of findings, specified by a scan name (test01 to test50), a 3D
position (x, y, and z coordinate) and a degree of suspicion p. In order to limit the amount of
computational processing required for the evaluation, only the 2000 most suspicious findings
are analyzed. In the evaluation procedure it is determined for each finding if its distance to
any nodule (relevant finding) in the scan is less than 1.5 times the radius of that nodule.
If so, this signifies a hit. The factor 1.5 is used to make sure a ‘near hit’ is allowed, and
to compensate for the fact that nodules are not perfectly spherical while distances between
center points are used in the computations. We experimented with higher and lower values
for this factor but found the overall results to be very stable for a wide range of values.
If a hit on a relevant finding is produced, the finding will count as a true positive (TP)
and increase the overall average sensitivity of the algorithm. The relevant finding is then
removed from the reference set so that it can ‘hit’ only once. If no hit is produced, it is
determined if the distance of the finding to any irrelevant finding in the scan is less than 1.5
times the radius of that finding. If so, the finding does not count as true positive, nor as
false positive; it will simply be discarded. Otherwise, the finding will be considered a false
positive (FP).
3.3 FROC analysis
Results are evaluated with free-response receiver operating characteristic (FROC) analysis
(see [1], Chapter 5). This means that the sensitivity (the fraction of true nodules in all test
scans detected by the system, given by TP/n where n is the total number of relevant findings
in all scans, so n = 207 in this study) is plotted as a function of the average number of false
positive markers per scan (given by FP/m where m is the total number of scans, so m = 50
in this study). To obtain a point on the FROC curve, only those findings of a CAD system
whose degree of suspicion p ≥ t, where t is a threshold, are selected, and the number of
false positives FP and true positives TP is determined, according to the procedure outlined







Figure 1: Examples of relevant and irrelevant findings. In every box a nodule is displayed
in a sagittal, coronal and axial view, 35 voxels (approximately 25 mm) around the center
point using a lung window (center -600 HU, width 1600 HU). The top row shows three
small nodules, (a) an isolated nodule of 4.4 mm; (b) a pleural nodule of 4.2 mm and (c)
a peri-fissural nodule of 4.8 mm (the thin line visible on each view is the fissure). The
second row shows three large nodules, (d) a nodule of 5.9 mm with vascular attachments;
(e) a ground-glass nodule of 5.4 mm (a relatively rare finding and therefore not used as a
separate category in this study) and (f) a large pleural nodule (18.4 mm). The third row
shows nodules that were too small (below 4 mm) to be relevant. Nodules measure (g) 3.2
mm, (h) 3.5 mm, and (i) 2.3 mm, respectively. The fourth row (j-l) shows three examples of
calcified nodules. Calcification is a benign characteristic and therefore these were considered
irrelevant findings. Even with the used window level it is evident that the nodules are
too bright (dense). The last row shows several lesions that were not considered nodules,
but (m) apical scarring, (n) pleural thickening and a (o) a nodular abnormality next to an
emphysematous bulla, unrelated to lung cancer.
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that p value as the threshold t. Between these points, straight lines are drawn to produce
the FROC curve. The point with the lowest false positive rate is connected to (0,0). From
the point with the highest false positive rate, the FROC curve is extended by a straight
horizontal line.
3.4 Scoring system
To extract a single score from the FROC curve, we measure the sensitivity at 7 pre-defined
false positive rates: 1/8, 1/4, 1/2, 1, 2, 4, and 8 FPs per scan. Note that since we connect
points on the FROC with straight lines as outlined above, we can always exactly compute
these sensitivities from the curve, even if there is no threshold t that precisely produces these
false positive rates. These 7 sensitivities are averaged to obtain an overall score of a system.
Clearly a perfect system will have a score of 1 and the lowest possible score is 0. Most CAD
systems in clinical use today have their internal threshold set to operate somewhere between
1 to 4 false positives per scan on average (most systems do not allow the user to vary the
threshold). To make the task more challenging, we included lower false positive rates than
those used in clinical practice in our evaluation. This determines if a system can also identify
a significant percentage of nodules with very few false alarms, as might be needed for CAD
algorithms that operate autonomously.
From the previous exposition, it should be clear that to obtain a good score, systems
should include enough findings in their results to reach the point of 8 FPs per scan. It is also
recommended to include enough distinct values for the degree of suspicion p to produce a
decent number of unique points on the FROC curve. In the extreme case that all findings are
assigned the same p value, there will be only one point on the curve defined, and a straight
line will be drawn from (0,0) to this point, and a horizontal line will extend from that point
to the right.
4 Methods
In this section a brief description is provided of six methods that have been applied to the
ANODE09 data set. These methods are listed as A to F in the remainder of this paper. Two
more methods have been submitted [18, 56] but their performance was much lower than that
of the other systems and therefore they have not been included in this analysis. For each
method the main steps of the algorithm are given. It is also listed what training data was
used. If available, typical performance of the system on previously used evaluation data is
provided.
This section also presents a general method to combine the output of multiple CAD
systems.
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4.1 Method A: Fujitalab
This method was developed at Gifu University, Japan. A key original element in this de-
tection approach is the analysis of nodule patterns with second-order local autocorrelation
features in 3D space and multi-regression analysis. The second-order local autocorrelation
features were expressed as a feature vector calculated from the voxel values in a 3×3×3
region. From a region of this size 235 combination patterns can be obtained, excluding com-
binations which can be obtained by parallel movement of the center of the region. For each
combination, the voxel values were multiplied, and the result was expressed as a component
of the feature vector.
Using multi-regression analysis, the weighting factor for these 235 elements and a constant
value were determined to indicate the training values. The training value was defined as the
likelihood of nodules. A nodular shadow gave a 3D Gaussian distribution for the training
output; on the other hand, a normal shadow gave a zero output.
The complete scheme involved the following steps: Segmentation of lung region; 3D
matched filtering using 3D Fourier Transforms; 3D gradient concentration filtering; identifi-
cation of initial candidates of nodules; false-positive reduction; analysis of the nodule images
from the 235 patterns using the multi-regression analysis; calculation of mutual correlation
between the training pattern and the estimated image; elimination of false-positives using a
rule-based approach; and calculation of the final detection results.
The lung region was segmented with gray-scale thresholding and 3D component labeling.
The gradient concentration filter was designed to enhance rounded convex regions by mea-
suring the degree of convergence of the gradient vectors around a point of interest. However,
this method of using gradient concentration filters for 3D image processing is time-consuming
and the segmentation results are not very satisfactory. Therefore, an improved gradient con-
centration filter that limits the region in which the degree of convergence is calculated was
used in this study. This limited region was considered to be the one that possibility includes
nodules such as rounded convex regions. The calculation time could be shortened by limiting
the calculation to a given region. Additionally, good segmentation results were obtained in
this case. As for the nodules, the output value of the degree of concentration showed a high
value compared with a blood vessel region. Then, pixels with a high output value of the
degree-of-concentration filter were used as starting points for a region growing technique and
in this way candidate regions were obtained.
Image features, i.e. size, degree of sphericity, aspect ratio, mean value of the degree of
convergence, and the maximum value of the degree of convergence, were used for elimination
of false positives.
Next, the auto-correlation features and multi-regression analysis was applied to the re-
maining candidates. The output of multi-regression is expected to be a continuous value;
hence, the comparison between the training patterns obtained in multi-regression and the
output also emphasized the nodular shadows. False-positives were therefore further elimi-
nated by using the correlation value and the volume of the remaining candidates.
For training, the five example cases from the ANODE09 study were used.
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4.2 Method B: Region Growing Volume Plateau
This method was developed at the University of Bari, Italy, in the MAGIC-5 research
project [12]. The method has been published [11] and was slightly modified for this study.
The system consisted of three steps: 1) the lung parenchymal volume was segmented in
the whole CT volume; 2) a region growing algorithm was iteratively applied to the segmented
volume to detect candidate nodules; 3) a double-threshold and a neural network were applied
to reduce false positives and classify the findings.
The lung parenchymal segmentation started with a simple-threshold 3D region growing
applied to the CT volume. The result is a binary mask of the respiratory system, containing
the trachea, the bronchi, and the lungs. The next step was the segmentation of the external
airways (trachea and bronchi) by a 3D region growing with wave-front simulation and suitable
stop conditions, allowing a proper handling of the hilar region. Particular attention was given
to detecting and solving the problem of the apparent fusion between the lungs, caused by
partial-volume effects. 3D morphology operations ensured the accurate inclusion of all the
nodules (internal, pleural, and vascular) in the segmented volume.
The second step detected candidate nodules inside the segmented volume. This func-
tionality was implemented by a region growing algorithm with an inclusion rule given by the
logical AND of two rules: a voxel was included in the region if its density averaged with its
first order neighbors was larger than a threshold t1, and a voxel was included in the region
if its density was larger than a threshold t2.
The threshold t1 was dynamically defined for each nodule candidate. Starting from an
initial value, t1 was decreased to obtain a curve providing the volume as a function of the
threshold. In general, this curve shows a decrease followed by a plateau due to difference in
density between the background and the nodule candidate. From this curve it is possible to
infer the best t1 value as the smallest in the range of the plateau.
The t2 threshold and the starting value of t1 were chosen in order to maximize the
detection rate (the fraction of selected nodules with respect to the total number of nodules
diagnosed by the radiologist). The seed points were searched automatically as follows: the
segmented volume is scanned until a voxel matching the inclusion rules (with thresholds t2
and t1) was found; this voxel was used as seed point and the growth was started. Once the
region was completely grown, it was removed from the scan and stored for further analysis.
Then the search for new seed points was restarted. This process was iterated until no more
seed points matching the inclusion rules were found.
For each candidate nodule the following features were calculated: sphericity, ellipticity,
maximum intensity, intensity standard deviation, Shannon entropy, volume, maximum ra-
dius. Almost all the FPs findings refer to candidates with too few voxels or to non-spherical
candidates and could be easily ruled out by a simple threshold on the volume and the spheric-
ity. A further reduction of false detections was obtained by means of a classification step
carried out by a supervised two-layered feed-forward neural network, trained with a gradient
descent learning rule and with a sigmoid transfer function.
The output of the neural network was used as degree of suspicion for each candidate.
Initially, results based on the training data described in [11] were submitted to the AN-
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ODE09 organizers. This is the training data also used by methods C and D. Later it was
found that training the system with the example scans of the ANODE09 data set produced
slightly better results on those example sets (tested through cross-validation) and therefore
these example scans were used in the final submission presented in this paper.
4.3 Method C: Channeler Ant Model
This method has been developed by researchers from the University of Torino, Italy and
CEADEN in Cuba within the framework of the MAGIC-5 research project [12]. The system
is aimed at segmentation of generic 3D objects of unknown shape and can therefore be
adapted to the automated search for lung nodules in low-dose CT scans.
The training data consisted of a set of low-dose lung CT scans collected by the Pisa Center
of the ITALUNG-CT trial, the first Italian randomized controlled trial for the screening of
lung cancer [53]. The CT scans were acquired with a 4-slice spiral CT scanner (Siemens
Volume Zoom) according to a low-dose protocol (tube voltage: 140 kV, tube current: 20 mA,
mean equivalent dose 0.6 mSv), with 1.25 mm slice collimation. Slices were reconstructed at
1 mm thickness, using a medium sharp reconstruction kernel (Siemens B50f). The number of
slices per scan was approximately 300, each slice being a 512 by 512 pixel matrix, with pixel
sizes ranging from 0.53 to 0.74 mm. The scans were annotated by experienced radiologists
with a dedicated annotation and visualization tool [27].
The method started with lung segmentation. The lung parenchyma was identified by
means of a 3D region growing method and a wavefront algorithm for the definition of the
lung surface on the inner side.
The Channeler Ant Model [14] was used as a segmentation method for the vessel tree
and the nodules candidates. Ant colonies were released on selected position of a 3D matrix,
i.e. the anthill. Each ant behaves according to a predefined set of rules [14] and releases
a quantity of pheromone while moving in the 3D environment defined by the lung volume.
When the colony was extinct and no more voxels matched the required conditions to become
anthills, the information provided by the pheromone map was analyzed. Ants explore (i.e.
live in) a 3D environment described in terms of positions and intensities of voxels. Their life
cycle is a sequence of atomic time steps, during which ants move from one voxel to one of its
26 neighbors. The behavior of ants was defined by a set of rules that specify how they move
in the environment, how much pheromone they release before moving to another location,
when they reproduce or die. The environment is defined by the voxel image intensities, which
can be thought of as the amount of available food for the colony: therefore, voxel intensities
should be progressively consumed when the number of visits increases. This mechanism,
required to make the colony evolve and explore the environment, was implemented in a
complementary way: whenever the limit to the maximum number of visits in a voxel was
reached, the voxel was no more available as a destination.
The ant colony started evolving from a voxel at the root of the vessel tree. When all the
ants in the colony have died, the process stopped and the segmented object was removed
from the original image and its coordinates were added to a list. In the remaining image, a
voxel with intensity greater than a predefined threshold became the new anthill and a new
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ant colony was deployed. If the number of voxels of an object was large with respect to the
maximum expected size of a nodule, as it happens with the bronchial and vascular trees, the
object was processed and smaller connected objects are looked for. The process finished when
all the voxels inside the matrix with intensity above the threshold had been analyzed. From
the segmented objects five features were extracted: number of voxels, maximum intensity,
average intensity, standard deviation of intensity and sphericity. A feed-forward artificial
neural network was implemented in order to classify the segmented objects.
A limitation of the method is that nodules with diameter smaller than 3 mm attached
to the vascular tree can not be detected. When the system was applied to the training data
set, using cross-validation, a sensitivity of 46% and 64% was obtained at an average of 2 and
6 false positives per scan, respectively.
4.4 Method D: Voxel-Based Neural Approach
This method was jointly developed by researchers from INFN and the University of Pisa,
Italy, and a researcher from Bracco Imaging S.p.A. within the MAGIC-5 research project [12].
The method is described in [28, 55]. A subset of the ITALUNG-CT data set [53] that was
also used in Method C was available to train and validate the system.
First, lung nodules were partitioned in two main classes, depending on their location in
the lung. A nodule was labeled either as internal if fully contained in the lung parenchyma or
as juxtapleural if connected to the pleura. The internal and juxtapleural nodule classes surely
included the ANODE09 categories of isolated and pleural nodules, respectively. Nodules
belonging to the other ANODE09 categories (peri-fissural and vascular) could either fall
into the internal or into the juxtapleural nodule class.
The system dealt differently with internal and juxtapleural nodules, by means of two
dedicated procedures: CADI for internal and CADJP for juxtapleural nodules. Both are
three-step procedures [2, 26, 28, 54, 55]:
1. Lung segmentation: an approach based on thresholding, region growing and morpho-
logical operators is implemented, once the scans have been isotropically resampled. In
order to outline the shape of the pleura irregularities (including juxtapleural nodules),
the lung boundaries were not smoothed. The identified lung mask, including vessels
and airway walls, was used for CADI, whereas its boundary was used for CADJP.
2. Candidate nodule selection:
• CADI: internal nodules were modeled as spherical objects with a Gaussian profile,
following the approach proposed in [41]; the 3D matrix of data was filtered with
a multi-scale filter function built to discriminate between spherical objects and
objects with planar or elongated shapes. The local maxima of the 3D filtered
matrix were the internal candidate nodule locations. A large number of false
positives were included at this stage, above all crossings between blood vessels.
• CADJP: to identify juxtapleural candidate nodules, pleura surface normals were
constructed and each voxel was assigned a score proportional to the number of
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normals intersecting in it. To deal with noise, cylinders with Gaussian profile were
considered instead of segments [52]. The local maxima of the 3D score matrix
were the juxtapleural candidate nodule locations. A large number of FPs was
found, mostly due to irregularities in the pleura surface (e.g. apical scars, pleural
thickening and plaques) and movement artifacts.
3. FP reduction: an original procedure, the Voxel-Based Neural Approach [26, 28, 54, 55],
was developed to reduce the number of FPs in the lists of internal and juxtapleural
candidate nodules. First, a region of interest (ROI) including voxels belonging to
the candidate nodule was defined from each location provided by the previous step.
For internal candidate nodules, a simple procedure based on relative thresholding was
implemented, while for juxtapleural candidate nodules a morphological opening-based
algorithm was used. The basic idea is to associate to each voxel of a ROI a feature
vector constituted by the intensity values of its 3D neighbors and the eigenvalues of
the gradient matrix and of the Hessian matrix. Feature vectors were then classified by
a three-layer feed-forward neural network which is trained to assign each voxel either
to the nodule or normal tissue target class. A ROI was assigned a degree of suspicion
p, defined as the percentage of voxels tagged as nodule by the neural classifier.
The final list of findings was simply obtained by merging the output lists of findings generated
by CADI and CADJP.
The training data used for CADI consisted of 30 internal nodules contained in 15 CT
scans, whereas 28 nodules belonging to 14 CT scans were used for CADJP. The diameters of
these nodules were in the 4–12 mm range; in particular, the 65% of them was in the 4–6 mm
range. Calcified solid nodules were not considered. As only a very small number of part-solid
or non-solid nodules were annotated in the available data set, they were not included.
System performance was evaluated on a prediction set of thirty other scans extracted from
the ITALUNG-CT data set, containing 35 internal and 32 juxtapleural nodules. A sensitivity
of 78% and 70% was measured at 8 and 4 false positive detection per scan, respectively [28].
4.5 Method E: ISI-CAD
This method was developed at the University Medical Center Utrecht, the Netherlands, by
the group who organized the ANODE09 study. The method is described in detail in [47]
and [48].
First the scan was subsampled to isotropic resolution and axial slices of 256 by 256.
The lungs were segmented by region growing and post-processing, including morphological
smoothing of the lung boundaries [61]. To extract nodule candidates, the shape index and
curvedness were computed at a fixed scale of 1 voxel. Voxels for which these values are within
preset ranges are clustered into a candidate structure. This procedure yielded on average
around 700 structures per scan.
False-positive candidates are removed by means of a two-step approach using k-nearest
neighbor classification (kNN). The kNN classifiers are trained using features of the image
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intensity gradients and gray-values in addition to further measures of shape index and curved-
ness profiles in the candidate regions. The initial classification step uses a small number of
relatively simple features to quickly reduce the most obviously incorrect candidates. These
are not further processed. After this first stage around 80 candidates per scan remain. The
second classifier employs more features of higher complexity in order to classify the more
ambiguous remaining candidates as accurately as possible. A total of 135 features were ini-
tially considered as being potentially useful. For both classification steps, sequential forward
floating selection was employed in the training stage to identify the most useful features.
The training data consisted of data from 722 scans from the NELSON screening program,
which is the same data source as the ANODE09 data set, giving this method a unique
advantage over the other methods considered in this paper. The ANODE09 scans are from
different subjects that those in the training data. In previous work [48], the method was
tested on 813 NELSON scans and detected 80% of annotated nodules at an average of 4.2
false-positive detections per scan.
4.6 Method F: Philips Lung Nodule CAD
The final method in this paper is a commercially available algorithm. We evaluated the
Philips Lung Nodule CAD option that is part of the Lung Nodule Assessment (LNA-
K023785) application that runs in the CT workstation called Extended Brilliance Workspace
(Philips Medical Systems, Cleveland, OH). This is a general purpose viewing and processing
workstation for medical images with several packages for dedicated CT image analysis on-
board of which nodule analysis is one. The software produces a number of markers per CT
scan. This number cannot be adjusted (as is the case in most commercial CAD software).
The software also does not return voxel coordinates. The markers were presented in a list
box as CAD1, CAD2, CAD3, and so on, depending on how many marks were available for a
particular case. It was our impression that items higher in this list corresponded to more sus-
picious findings. In order to convert the software output to a format suitable for ANODE09,
we therefore proceeded as follows. Two medical students processed the 50 ANODE09 cases
and located the markers in a separate software program to obtain approximate voxel loca-
tions. A finding that was listed as CAD1 received a likelihood of 1, a finding that was listed
as CAD2 received a likelihood of 1/2, and so on. In this way, the first point of the FROC
curve that will be generated consists of only the CAD1 marks of all cases, the second point
on the curve consists of CAD1 and CAD2 marks, and so on. Note that it cannot be taken
for granted that the first finding of one scan has the same absolute relevance of the first
finding of another scan. Thus the real FROC of the system will necessary be unpredictably
different, and will probably be slightly better than what is reported here. The only point
that we know for sure to be correct is the point with the lowest false positive rate at the
highest sensitivity, where all marks are used.
The Philips Lung Nodule CAD comes with extensive documentation on its use and
describes the results of clinical studies to investigate its effectiveness. The documentation
is brief, however, about the working of the algorithm. It states that the scheme consists of
four principal parts. First, the lungs are segmented. Next, seed points are determined from
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2D analysis of slices. From these seeds, 3D features and metrics are computed. Finally,
the list of candidates is reduced by filtering each candidate on its features and metrics and
the application of simple accept/reject rules. From this description, we believe the method
is comparable to the algorithm outlined in two publications by Wiemker and co-workers
[63, 64]. The characteristics and total number of training scans that were used to develop
the accept/reject rules is unknown.
In a clinical study where four sites contributed 110 subject cases, the system was found
to yield between 5 and 8 false positive markers per case and have a sensitivity of around
60% for nodules that were determined by a consensus panel and around 36% for all nodules
indicated by the radiologists in the study. These results are reported in the documentation
of the Extended Brilliance Workspace but a literature reference is not given.
4.7 System combination
Like many tasks in medical image analysis, nodule detection is a complicated problem that
can be approached in many different ways. The detection algorithms outlined above indeed
appear substantially different. If multiple methods focus on different aspects of a problem, it
is not unlikely that a proper combination of their output would yield a higher performance
than any of the methods stand-alone.
To investigate this, we propose a way to combine the results of multiple nodule CAD
systems without access to their internals, like the feature values of candidates that are input
to an internal classifier. The proposed blending method employs only the findings (coordi-
nates and degree of suspicion p for each finding) and information about the performance of
individual systems. It uses this performance information in such a way that systems with
better performance are implicitly weighed more heavily in the combination. Without such
knowledge, making a proper combination of systems with widely different performance levels
is difficult.
More precisely, we assume that, before combining, the results of a CAD system on an
evaluation set with known truth are available. Let pi, i = 1, . . . , n denote the likelihood of
each CAD finding. Every unique value of p in the set of n findings corresponds to a point
on the FROC curve of the system, as explained in Section 3.3. For every unique p value we
can compute the number of true positives TP when we consider all findings with pi >= p as
positive. We can also compute the number of false positives FP we obtain at this threshold
(disregarding irrelevant findings). Now we associate with each p a value
f(p)→ TP
FP + TP + 1
, (1)
where the factor +1 has been added in the denominator to avoid division by zero in the
exceptional situation that all findings are irrelevant, in which case both TP and FP equal
zero. The values f(p) are approximately equal to the probability that a finding in the
evaluation set with likelihood p or higher represents a true nodule. Such probabilities are
natural measures to combine.
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To combine systems, we compute f(p) for every finding from every system. All findings
are sorted so that we have fi, i = 1, . . . , n and fi >= fj if i < j. Starting at fi with i = 1,
it is checked for all findings fj, j = i + 1, . . . , n if they correspond with fi. In this study
we used the simple rule that findings within 5 voxels of each other (and obviously located
in the same scan) are corresponding. A more elaborate criterion, such as the one used to
compute the FROC curves in this study, could be used instead, but this is not possible as
no segmentations or effective diameters of the input findings are available. If two findings fi
and fj correspond, we set
fi → fi + fj,
remove fj from the list of findings and continue the procedure. It is easy to see that this is
conceptually similar to averaging the probabilities for each finding across all systems, where
undetected findings correspond to a zero probability: we add up the findings we are able
to match across systems and if a system does not detect a particular finding, nothing will
be added. Note that systems with low performance have f values that are close to zero for
(nearly) all their findings, and these systems are therefore automatically weighed less heavily
in the combination.
5 Results
The results for all systems are tabulated in Tables 1 and 2. There is considerable variation
in the overall scores. System E clearly outperforms the other schemes. The results for the
different classes of nodules reveal more subtle differences between the systems. For example,
system F scores much better for larger nodules compared to smaller ones, but for other
systems the opposite holds. In general, isolated nodules seem easier to detect than peri-
fissural and vascular nodules, and pleural nodules are the hardest. But for some systems
this general trend does not hold.
Table 4 shows the results for all 57 possible combinations that can be made from 6
systems. It is evident that blending the output of CAD systems can lead to spectacular
improvements in performance. The combination of systems B and C, with individual scores
of 0.291 and 0.254, leads to a system with a score of 0.437, an increase of 0.146 compared
to B alone. An even larger improvement is obtained when systems C and D are combined.
This leads to a system with a score of 0.471 and the results of this system are also given
in Table 3 where it can be seen that for some categories of nodules performance almost
doubles. Combining the best performing system (E) with one other system mostly leads to
smaller improvements, and even some slight deteriorations. But, in the case of combining E
with C, performance improves to from 0.632 to 0.659, the best combination of two systems.
Combining E with D scores lower, although D scores higher than C. When all systems are
combined an overall score of 0.685 is obtained, compared to 0.632 for system E alone. The
best combination without system E is the combination of all remaining systems. This system
is also tabulated in Table 3. It leads to the highest improvement compared to any single
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System A
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.154 0.171 0.231 0.282 0.299 0.316 0.316 0.253
large nodules 0.111 0.122 0.144 0.178 0.178 0.189 0.189 0.159
isolated nodules 0.238 0.262 0.310 0.381 0.381 0.381 0.381 0.333
vascular nodules 0.116 0.140 0.186 0.209 0.221 0.244 0.244 0.194
pleural nodules 0.051 0.051 0.068 0.119 0.136 0.153 0.153 0.104
peri-fissural nodules 0.171 0.171 0.286 0.314 0.314 0.314 0.314 0.269
all nodules 0.135 0.150 0.193 0.237 0.246 0.261 0.261 0.212
System B
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.111 0.171 0.222 0.299 0.453 0.538 0.581 0.339
large nodules 0.111 0.122 0.144 0.222 0.278 0.344 0.367 0.227
isolated nodules 0.214 0.262 0.310 0.476 0.595 0.667 0.667 0.456
vascular nodules 0.105 0.116 0.163 0.198 0.267 0.337 0.360 0.221
pleural nodules 0.017 0.017 0.017 0.085 0.220 0.339 0.390 0.155
peri-fissural nodules 0.171 0.314 0.371 0.457 0.600 0.686 0.743 0.478
all nodules 0.111 0.150 0.188 0.266 0.377 0.454 0.488 0.291
System C
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.009 0.017 0.077 0.205 0.342 0.530 0.624 0.258
large nodules 0.089 0.111 0.222 0.267 0.322 0.356 0.378 0.249
isolated nodules 0.024 0.048 0.119 0.333 0.476 0.595 0.667 0.323
vascular nodules 0.070 0.093 0.151 0.198 0.302 0.442 0.488 0.249
pleural nodules 0.034 0.034 0.153 0.203 0.220 0.356 0.441 0.206
peri-fissural nodules 0.057 0.057 0.171 0.286 0.457 0.514 0.571 0.302
all nodules 0.043 0.058 0.140 0.232 0.333 0.454 0.517 0.254
Table 1: Results for systems A, B, and C. For each of the nodule categories and for all
nodules, sensitivity is provided at seven levels of average numbers of false positives per scan,
2−3,...,+3. In the final column, the average of the sensitivities at the seven false positive levels




FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.107 0.205 0.299 0.393 0.462 0.564 0.624 0.379
large nodules 0.017 0.022 0.089 0.144 0.222 0.333 0.444 0.182
isolated nodules 0.149 0.214 0.405 0.571 0.571 0.667 0.690 0.467
vascular nodules 0.055 0.116 0.198 0.256 0.372 0.453 0.547 0.285
pleural nodules 0.013 0.034 0.068 0.153 0.220 0.356 0.475 0.188
peri-fissural nodules 0.089 0.171 0.229 0.257 0.286 0.429 0.514 0.282
all nodules 0.068 0.126 0.208 0.285 0.357 0.464 0.546 0.293
System E
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.470 0.491 0.573 0.658 0.711 0.761 0.778 0.634
large nodules 0.423 0.483 0.567 0.611 0.714 0.778 0.822 0.628
isolated nodules 0.548 0.595 0.595 0.619 0.619 0.643 0.643 0.609
vascular nodules 0.570 0.573 0.616 0.686 0.757 0.802 0.849 0.693
pleural nodules 0.052 0.140 0.322 0.475 0.630 0.695 0.729 0.435
peri-fissural nodules 0.629 0.643 0.743 0.771 0.804 0.886 0.886 0.766
all nodules 0.450 0.488 0.570 0.638 0.712 0.768 0.797 0.632
System F
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.019 0.038 0.075 0.133 0.186 0.278 0.359 0.155
large nodules 0.053 0.106 0.195 0.306 0.395 0.539 0.711 0.329
isolated nodules 0.044 0.088 0.152 0.222 0.260 0.381 0.429 0.225
vascular nodules 0.038 0.077 0.145 0.246 0.334 0.437 0.558 0.262
pleural nodules 0.012 0.025 0.057 0.112 0.136 0.229 0.424 0.142
peri-fissural nodules 0.032 0.063 0.155 0.295 0.418 0.543 0.571 0.297
all nodules 0.034 0.067 0.127 0.208 0.276 0.392 0.512 0.231
Table 2: Results for systems D, E, and F. For each of the nodule categories and for all
nodules, sensitivity is provided at seven levels of average numbers of false positives per scan,
2−3,...,+3. In the final column, the average of the sensitivities at the seven false positive levels




FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.393 0.436 0.479 0.547 0.615 0.650 0.726 0.549
large nodules 0.200 0.289 0.322 0.356 0.389 0.489 0.533 0.368
isolated nodules 0.548 0.619 0.667 0.667 0.690 0.714 0.738 0.663
vascular nodules 0.302 0.349 0.372 0.419 0.465 0.535 0.616 0.437
pleural nodules 0.153 0.203 0.288 0.407 0.508 0.576 0.661 0.400
peri-fissural nodules 0.314 0.457 0.457 0.514 0.543 0.629 0.629 0.506
all nodules 0.309 0.372 0.411 0.464 0.517 0.580 0.643 0.471
System A+B+C+D+F
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.453 0.513 0.598 0.650 0.702 0.795 0.821 0.647
large nodules 0.344 0.389 0.456 0.511 0.556 0.656 0.722 0.519
isolated nodules 0.619 0.619 0.738 0.738 0.742 0.762 0.786 0.715
vascular nodules 0.360 0.419 0.477 0.512 0.593 0.709 0.779 0.550
pleural nodules 0.254 0.271 0.407 0.525 0.542 0.695 0.763 0.494
peri-fissural nodules 0.514 0.657 0.657 0.686 0.771 0.829 0.829 0.706
all nodules 0.406 0.459 0.536 0.589 0.638 0.734 0.778 0.592
System A+B+C+D+E+F
FPs/scan 1/8 1/4 1/2 1 2 4 8 average
small nodules 0.496 0.573 0.684 0.761 0.803 0.821 0.872 0.716
large nodules 0.389 0.411 0.578 0.678 0.778 0.811 0.867 0.644
isolated nodules 0.595 0.619 0.643 0.738 0.786 0.810 0.810 0.714
vascular nodules 0.430 0.465 0.616 0.721 0.802 0.826 0.907 0.681
pleural nodules 0.254 0.356 0.542 0.627 0.695 0.746 0.831 0.579
peri-fissural nodules 0.629 0.657 0.771 0.829 0.886 0.914 0.914 0.800
all nodules 0.449 0.502 0.638 0.725 0.792 0.816 0.870 0.685
Table 3: Results for three combined systems. System C+D is the best performing combi-
nations of two systems excluding system E. System A+B+C+D+F has the largest overall
performance improvement compared to any of its composing systems. The best result is
obtained for the combination of all systems (A+B+C+D+E+F). For each of the nodule
categories and for all nodules, sensitivity is provided at seven levels of average numbers of
false positives per scan, 2−3,...,+3. In the final column, the average of the sensitivities at the
seven false positive levels is given. The number in the bottom-right of each table can be
considered an overall score for the system.
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system in the combination, scoring 0.592, which is 0.299 higher than system D, the best
single system in this combination, alone.
Figure 2 shows the FROC curves for all nodules for all systems, including three combi-
nations. Figure 3 shows the same, but for all nodule categories separately.
6 Discussion
The six systems considered in this comparison show remarkably different results. This sup-
ports the notion that comparisons on the same database are important. There are two main
reasons for performance difference between systems: the underlying algorithm and the train-
ing data that is used to train the classifiers or to set the internal model parameters of the
system. The ANODE09 data set does not supply a separate set for training, as was done for
example in [30]. It would be interesting to compare systems that use identical training data,
however, this limits the possibilities for including certain systems that are used in clinical
practice or that have been used in previously published studies in the comparison.
Clearly the training data that has been used by the systems varies considerably. In
particular, system E has a distinct advantage over the other studies in that it has used a large
training set, originating from the same lung cancer trial, using the same scanners and scan
protocol. It is unclear how much of its better performance can be attributed to the difference
in training data. The performance of system E reported here is roughly comparable to that
reported in [47] and [48]. Method A and B both used the five example cases in the ANODE09
date set for training. Clearly this is a small training set, although it is representative of the
ANODE09 test data. Methods C and D used the same training data, originating from
an Italian lung cancer screening trial. This training set was also small compared to the
set used by system E. The results obtained by systems C and D on their training data,
tested by cross-validation are substantially better than those obtained on the ANODE09
data set. This indicates that there may be important differences between the Italian data
and the ANODE09 data, which can be related to the scans or to the type of annotations.
The Japanese team (Method A) has investigated the effect of changing training databases
when using the five ANODE09 example cases for testing and found substantial differences
depending on which training database was used. It is likely that all methods A through D
would improve if they would have more training data available. It is therefore impressive
that the combination of all systems except E approaches the score of E so closely. LIDC has
announced that a database with over 1000 CT scans will become publicly available, and this
will greatly facilitate investigations into the effect of type and size of training databases on
nodule detection performance.
The commercial system, F, does not achieve a very high score. It has a disadvantage
because the actual degree of suspicion used internally in the algorithm was not accessible
to the researchers who applied the system to the ANODE09 data. The strategy used to
construct intermediate points (see Section 4.6) is not optimal, and the shape of the FROC
curve suggests that as well. On the other hand, it is unlikely that knowing the proper p
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Figure 2: FROC curves of all six systems and three combinations. The horizontal axis is
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Figure 3: FROC curves of all six systems and three combinations for each of the nodule
categories (small, large, isolated, vascular, pleural and peri-fissural).
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 0.371 0.291 0.080
 0.336 0.254 0.082
 0.372 0.293 0.079
 0.606 0.632 -0.026
 0.330 0.231 0.099
 0.437 0.291 0.146
 0.468 0.293 0.175
 0.604 0.632 -0.028
 0.413 0.291 0.122
 0.471 0.293 0.178
 0.659 0.632 0.027
 0.361 0.254 0.107
 0.636 0.632 0.004
 0.445 0.293 0.152
 0.634 0.632 0.002
 0.471 0.291 0.180
 0.498 0.293 0.205
 0.607 0.632 -0.025
 0.451 0.291 0.160
 0.477 0.293 0.184
 0.649 0.632 0.017
 0.418 0.254 0.164
 0.625 0.632 -0.007
 0.452 0.293 0.159
 0.640 0.632 0.008
combination score best single ∆
 0.522 0.293 0.229
 0.625 0.632 -0.007
 0.494 0.291 0.203
 0.637 0.632 0.005
 0.560 0.293 0.267
 0.641 0.632 0.009
 0.668 0.632 0.036
 0.526 0.293 0.233
 0.678 0.632 0.046
 0.668 0.632 0.036
 0.546 0.293 0.253
 0.640 0.632 0.008
 0.518 0.291 0.227
 0.636 0.632 0.004
 0.568 0.293 0.275
 0.651 0.632 0.019
 0.664 0.632 0.032
 0.528 0.293 0.235
 0.687 0.632 0.055
 0.663 0.632 0.031
 0.659 0.632 0.027
 0.585 0.293 0.292
 0.664 0.632 0.032
 0.666 0.632 0.034
 0.689 0.632 0.057
 0.668 0.632 0.036
 0.592 0.293 0.299
 0.672 0.632 0.040
 0.677 0.632 0.045
 0.702 0.632 0.070
 0.690 0.632 0.058
 0.685 0.632 0.053
Table 4: Results of all combinations that can be obtained from six systems. The filled and
open squares indicate which systems have and have not been included in the combination, so
for example  is the combination of systems B, C, and F. The score is the average
sensitivity at the seven false positive levels 2−3,...,+3. The best score of any single system
included in the combination is also given, and the difference between the combination score
and the best score of a single system in the combination is listed under ∆.
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at lower false positive levels. System F, and system E and A as well, might have achieved
slightly higher scores if more findings had been included in their result set so that the point
of 8 false positive detections per scan had been reached.
System F is peculiar in that it detects larger nodules much better than smaller ones,
whereas for the other systems this is the other way around, with C and E showing comparable
performance for large and small nodules. Intuitively, one would expect better performance for
large nodules, but one reason for better performance for smaller nodules could be that these
are more often isolated. Also smaller nodules are more common so probably occur more
in CAD systems’ training data, and smaller nodules are more likely to have the classical
appearance of a simple sphere, whereas larger nodules are more likely to be lobulated or
spiculated. It could also be a pre-determined setting of system F to give smaller potential
nodules a lower degree of suspicion. From a clinical point of view, this makes sense as larger
nodules are much more likely to represent malignancies.
The results for the different categories of nodules reveal interesting information. Some
systems are particularly suited to detecting isolated nodules (systems D and B, for example)
which could be the result of a high prevalence of these type of nodules in their training
data. Some systems are not very adept at detecting peri-fissural or pleural nodules. Such
weaknesses of systems to handle particular types of nodules can be compensated by other
systems when combining them.
We believe that much more than identifying ‘good’ and ‘bad’ systems, the real value of
this study lies in the demonstration that the combination of systems yields such spectacular
improvements. As we noted, the methods have different strengths and weaknesses. The
effect of combining systems reveals how complementary they are. System F is not a very
good system in terms of overall performance, and adding it to system E, the best performing
system, leads only to minor improvements (0.632 to 0.634), but when putting all systems
together, leaving out system F decreases performance from 0.685 to 0.668. Apparently system
F is in some ways different from the other systems. Note that this complementarity is not
observed for systems A and B. Leaving them out for the total combination even slightly
improves results.
More sophisticated blending strategies could be devised than the one employed here. The
technique we applied is similar to the averaging rule in classifier combination strategies [34].
It requires knowledge about the performance of a system on a reference database, in the form
of an FROC curve. That curve is used in a look-up table to convert the degree of suspicion
as reported by a system, which has an arbitrary scale, to an indication of the probability that
a finding with that degree of suspicion or higher is truly a nodule in the reference database.
This transformation is given by Eq. 1. The requirement that an FROC curve of each system
is needed may seem a limiting factor to use this combination strategy in a clinical setting.
However, we believe this is not the case. If an institution would have access to multiple
CAD systems, the only thing that would be required is to establish a reference for a test set
representative for that clinic. After running the CAD systems on that test set, which is a
useful exercise to get a feeling for the performance of the CAD systems anyway, they can be
readily combined using Eq. 1 and the algorithm in Section 4.7. Developing more effective
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ways to combine multiple CAD systems is a promising direction for future research.
Although the combined system performs quite well, it is important to analyze what could
be done to further improve results. Two approaches are possible: focus on further reduction
of false positives at the left end of the FROC curve or improve sensitivity. For the latter
it can be insightful to inspect the missed nodules at the right end of the FROC curve.
We visually inspected nodules that were missed or only detected at very high false positive
levels (Figure 4, last row), and compared them with nodules that are detected at very low
false positive levels (Figure 4, middle row). The very suspicious nodules are indeed clear,
prototypical examples of nodules. The difficult nodules were somewhat less conspicuous, but
it was hard to detect any clearly identifiable characteristics among these cases that could be
used as an inspiration to improve the performance of CAD systems.
To analyze the characteristics of the false positives, we visually inspected the 100 most
suspicious FPs of the combined system. Although the variation among those findings was
large, some broad categories could be discerned. It appeared that vessel branchings were the
most common cause for false positives. This is in agreement with observations in [26] and
[15, 38] regarding the false positives produced by other commercial systems not included in
this study. Interestingly, there were quite a few findings where two or more vessels seemed to
be in contact with each other, forming a point that looked nodular to anyone not tracing the
vessel tree through several sections. Figure 4(a) shows an example. Especially on the sagittal
view it is clear that multiple vessels meet at the location of the perceived nodule. An accurate
dedicated vessel segmentation algorithm might be employed to reduce the occurrence of such
false positives. Methods B and C include vessel segmentation and this may be one reason
why they work well in combination with other methods.
Another common source of false positives are apparent protrusions mimicking pleural
nodules at locations where high density bony structures, such as ribs, vertebrae and the
sternum are close to the pleural surface of the lung or even pressing against it. An example
is given in Figure 4(b). Using the output of a separate segmentation of the bony anatomy
might prevent such false positives. Another common source of false positives are other lesions
such as small scars.
Many false positives are small and this indicates that systems could eliminate them by
adding an algorithm that segments the findings and discards findings that are below 4 mm,
or gives them a lower degree of suspicion. It is likely that some systems were not designed
to discard such small findings. This is suggested by the curves in Figure 5 where the results
of all systems are given if the relevant and irrelevant findings are swapped in the reference
standard. Most irrelevant findings are nodules smaller than 4 mm in diameter, and Figure 5
shows that some methods still detect quite a few of these very small nodules while others do
not. At 1 FP per scan, all systems are more sensitive for the detection of relevant findings
than for the detection of irrelevant ones.
The ANODE09 study is the first to compare and combine a large group of CAD systems
for nodule detection on a single database, but the study also has some limitations. Most
importantly, all data originates from a single hospital where all scans have been acquired





Figure 4: Examples of false positives and easy and hard to detect nodules. In every box a find-
ing is displayed in a sagittal, coronal and axial view, 35 voxels (approximately 25 mm) around
the center point using a lung window (center -600 HU, width 1600 HU). The top row shows
false positives with a high degree of suspicion in the combined system A+B+C+D+E+F.
(a) is a point where multiple vessels meet as is especially apparent from the sagittal view;
(b) is an apparent protrusion caused by bony structures close to the lung pleura; (c) is an
apical scar. Many of these scars were listed as irrelevant findings, but this one is not very
nodular in appearance and was not marked. The last two rows show actual nodules that


























Figure 5: FROC curves of all six systems for the detection of irrelevant findings. In this
analysis the relevant findings are ignored (relevant and irrelevant findings have been switched)
and therefore false positive levels are directly comparable to those in Figure 2
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are from subjects from a particular screening population. In clinical practice, CAD systems
should be capable of operating with diverse input data. Also the reading protocol and
characteristics of findings are particular to this study and this influences the reported results.
For example, a system that has not been designed to detect nodules under 5 mm diameter is
clearly at a disadvantage, although it should obtain good results for the large nodule category.
Fotin et al. [21] proposed a different evaluation strategy where the implicit inaccuracy for
measuring the size of smaller lesions is taken into account in the evaluation strategy. This
has not been done in the current work.
There are few large lesions in this data set and one could argue that those are actually
the most important for a CAD system to detect as they are most likely to represent cancer.
This would be especially true if CAD were used as a first reader or as a pre-screening system
where it would select cases or locations to be inspected by radiologists. On the other hand,
this is currently not the usual mode of operation for a CAD system and some radiologists
actually prefer that CAD finds especially small and subtle nodules. They do not mind if some
large and obvious nodules are missed, because they are able to find these themselves. How
small and subtle those cases that CAD should detect should be will likely vary across users.
Different users have different preferences. In this study, the discussion of which nodules a
CAD system should detect is somewhat circumvented by the introduction of the category of
irrelevant findings. In the future it would be interesting to repeat the study on a larger data
set, containing more variety in nodules, and with data originating from multiple hospitals,
different populations, multiple scanner types from different vendors and a reasonable variety
of scanning protocols.
In this study we have not addressed the question of whether the output of the CAD
system is actually beneficial for human experts. This has been researched extensively in
clinical studies, and may be investigated in the future for the ANODE09 set.
Finally, only a small number of published and commercially available systems have been
applied to the ANODE09 data set as of yet. We hope that in the future other groups will
upload the results of their algorithms to help the research community in the identification
of open challenges regarding this important CAD application.
7 Conclusions
A publicly available database and web-based framework for the evaluation of CAD algo-
rithms for nodule detection in thoracic CT scans has been presented. The results of six
algorithms are compared and combined. The introduction of irrelevant findings ensures that
false positives of the algorithms are true errors and not nodules that do not meet the par-
ticular requirements of the study. A simple but effective method for the combination of
various systems has been proposed. This combination method requires knowledge about
the performance of the systems to be combined, in the form of an FROC curve on a data
set with a known number of positive findings. Combining the findings of different systems
appears to be a very powerful method to improve the performance of CAD systems. The
combination of six CAD algorithms is able to detect 80% of all nodules at the expense of
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only 2 false positive detections per scan and 65% of all nodules with only 0.5 false positives.
This suggests that blending detection algorithms is a promising direction for future research
in CAD.
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